Skin irritation and sensitization: Mechanisms and new approaches for risk assessment - 2. Skin sensitization

Skin Pharmacology and Physiology

Volumn 21, Issue 4, 2008, Pages 191-202

  Basketter, D ^a   Darlenski, R ^b   Fluhr, J W ^c  

^a DABMEB CONSULTANCY LTD   (United Kingdom)

^b MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^c Bioskin   (Germany)

Author keywords

Allergic contact dermatitis; Local lymph node assay; Risk assessment

Indexed keywords

HAPTEN;

ADAPTIVE IMMUNITY; COST OF ILLNESS; GUINEA PIG; HUMAN; LOCAL LYMPH NODE ASSAY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SKIN ALLERGY; SKIN IRRITATION; SKIN SENSITIZATION; SOCIAL ASPECT; T LYMPHOCYTE;

ANIMALS; DERMATITIS, ALLERGIC CONTACT; DERMATITIS, IRRITANT; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GUINEA PIGS; HUMANS; LOCAL LYMPH NODE ASSAY; RISK ASSESSMENT; SKIN TESTS;

EID: 47249087716     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000135635     Document Type: Review

References (91)

1. Rustemeyer T, Hoogstraten I, Blomberg BV, Scheper R: Mechanisms in allergic contact dermatitis; in Frosch P, Menné T, Lepoittevin J-P (eds): Contact Dermatitis. Heidelberg, Springer, 2006, pp 11-44.
2. Frosch P, Menné T, Lepoittevin J-P: Contact Dermatitis, ed 4. Heidelberg, Springer, 2006.
3. EEC: EEC Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances. Off J Eur Commun, 196, 1967, pp 1-98.
4. EC: Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Off J Eur Union, L 396/1, 2006.
5. http://www.unece.org/trans/danger/publi/ghs/ghs_rev00/English/ GHS-PART-3e.pdf.2007.
6. Basketter DA, Andersen KE, Liden C, Van Loveren H, Boman A, Kimber I, Alanko K, Berggren E: Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis 2005;52:39-43.
7. Andersen KE, Maibach HI: Contact Allergy Predictive Tests in Guinea Pigs. Basel, Karger, 1985.
8. Buehler EV: Delayed contact hypersensitivity in the guinea pig. Arch Dermatol 1965;91:171-177.
9. Magnusson B, Kligman A: Allergic Contact Dermatitis in the Guinea Pig. Identification of Contact Allergens. Springfield, Thomas, 1970.
10. OECD: Guidelines for testing of chemicals. No 406: skin sensitization. OECD, 1992.
11. NIH: The murine local lymph node assay: a test method for assessing the allergic contact dermatitis potential of chemicals/compounds. No 99-4494. NIH, 1999.
12. OECD: Guidelines for testing of chemicals. No 429: skin sensitization: the local lymph node assay. OECD, 2002.
13. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS: ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel. Regul Toxicol Pharmacol 2001;34:258-273.
14. Basketter DA, Angelini G, Ingber A, Kern PS, Menne T: Nickel, chromium and cobalt in consumer products: revisiting safe levels in the new millennium. Contact Dermatitis 2003;49:1-7.
15. Felter SP, Robinson MK, Basketter DA, Gerberick GF: A review of the scientific basis for uncertainty factors for use in quantitative risk assessment for the induction of allergic contact dermatitis. Contact Dermatitis 2002;47:257-266.
16. Felter SP, Ryan CA, Basketter DA, Gilmour NJ, Gerberick GF: Application of the risk assessment paradigm to the induction of allergic contact dermatitis. Regul Toxicol Pharmacol 2003;37:1-10.
17. Api AM, Basketter DA, Cadby PA, Cano MF, Ellis G, Gerberick GF, Griem P, McNamee PM, Ryan CA, Safford B: Dermal sensitization quantitative risk assessment (QRA) for fragrance ingredients. Regul Toxicol Pharmacol, in press.
18. Basketter D, Pease C, Kasting G, Kimber I, Casati S, Cronin M, Diembeck W, Gerberick F, Hadgraft J, Hartung T, Marty JP, Nikolaidis E, Patlewicz G, Roberts D, Roggen E, Rovida C, van de Sandt J: Skin sensitisation and epidermal disposition: the relevance of epidermal disposition for sensitisation hazard identification and risk assessment. The report and recommendations of ECVAM workshop 59. Altern Lab Anim 2007;35:137-154.
19. Lepoittevin J-P: Molecular aspects of allergic contact dermatitis; in Frosch P, MennA T, Lepoittevin J-P (eds): Contact Dermatitis. Heidelberg, Springer, 2006, pp 45-68.
20. Roberts DW, Patlewicz G, Kern PS, Gerberick F, Kimber I, Dearman RJ, Ryan CA, Basketter DA, Aptula AO: Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization. Chem Res Toxicol 2007;20:1019-1030.
21. Ashby J, Hilton J, Dearman RJ, Kimber I: Streptozotocin: inherent but not expressed skin sensitizing activity. Contact Dermatitis 1995;33:165-167.
22. Landsteiner K, Chase MW: Studies on the sensitization of animals with simple chemical compounds. 6. Experiments on the sensitization of guinea pigs to poison ivy. J Exp Med 1939;69:767-784.
23. Landsteiner K, Jacobs J: Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1935;61:643-657.
24. Mayer RL: Group sensitization to compounds of quinine structure and its biochemical basis. Role of these substances in cancer. Prog Allergy 1954;4:79-172.
25. Dupuis G, Benezra C: Allergic Contact Dermatitis to Simple Chemicals: A Molecular Approach. New York, Dekker, 1982.
26. Berl V, Barbaud A, Lepoittevin JP: Mechanism of allergic contact dermatitis from propacetamol: sensitization to activated N,N-diethylglycine. Contact Dermatitis 1998;38:185-188.
27. Bertrand F, Basketter DA, Roberts DW, Lepoittevin JP: Skin sensitization to eugenol and isoeugenol in mice: possible metabolic pathways involving ortho-quinone and quinone methide intermediates. Chem Res Toxicol 1997;10:335-343.
28. Franot C, Roberts DW, Basketter DA, Benezra C, Lepoittevin JP: Structure-activity relationships for contact allergenic potential of gamma,gamma-dimethyl-gamma-butyrolactone derivatives. 2. Quantitative structure-skin sensitization relationships for alpha-subst ituted-alpha-methyl- gamma, gamma-dimethyl-gamma-butyrolactone s. Chem Res Toxicol 1994;7:307-312.
29. Lepoittevin JP, Drieghe J, Dooms-Goossens A: Studies in patients with corticosteroid contact allergy. Understanding cross-reactivity among different steroids. Arch Dermatol 1995;131:31-37.
30. 13C-enriched methyl alkanesulfonates: new lipophilic methylating agents for the identification of nucleophilic amino acids of proteins by NMR. Tetrahedron Lett 1992;33:3875-3878.
31. Roberts DW, Williams DL: The derivation of quantitative correlations between skin sensitisation and physio-chemical parameters for alkylating agents, and their application to experimental data for sultones. J Theor Biol 1982;99:807-825.
32. Basketter D, Dooms-Goossens A, Karlberg AT, Lepoittevin JP: The chemistry of contact allergy: why is a molecule allergenic? Contact Dermatitis 1995;32:65-73.
33. Smith CK, Hotchkiss SAM: Xenobiotics as skin sensitizers: metabolic activation and detoxification, and protein-binding mechanisms; in Smith CK, Hotchkiss SAM (eds): Allergic Contact Dermatitis: Chemical and Metabolic Mechanisms. London, Taylor and Francis, 2001, pp 119-205.
34. Aptula AO, Patlewicz G, Roberts DW: Skin sensitization: reaction mechanistic applicability domains for structure-activity relationships. Chem Res Toxicol 2005;18:1420-1426.
35. Roberts DW, Aptula AO, Patlewicz G: Mechanistic applicability domains for non-animal based prediction of toxicological endpoints. QSAR analysis of the Schiff base applicability domain for skin sensitization. Chem Res Toxicol 2006;19:1228-1233.
36. Roberts DW, Aptula AO: Determinants of skin sensitisation potential. J Appl Toxicol 2007, E-pub ahead of print.
37. Patlewicz G, Aptula AO, Uriarte E, Roberts DW, Kern PS, Gerberick GF, Kimber I, Dearman RJ, Ryan CA, Basketter DA: An evaluation of selected global (Q)SARs/expert systems for the prediction of skin sensitisation potential. SAR QSAR Environ Res 2007;18:515-541.
38. Landsteiner K, Chase MW: On group specific A substances. 3. The substance in commercial pepsin. J Exp Med 1936;63:813-817.
39. Landsteiner K, Jacobs J: Studies on the sensitization of animals with simple chemical compounds. J Exp Med 1936;64:625-639.
40. Basketter DA, Gerberick GF: An interlaboratory evaluation of the Buehler test for the identification and classification of skin sensitizers. Contact Dermatitis 1996;35:146-151.
41. Basketter DA, McFadden J, Evans P, Andersen KE, Jowsey I: Identification and classification of skin sensitizers: identifying false positives and false negatives. Contact Dermatitis 2006;55:268-273.
42. Steiling W, Basketter D, Berthold K, Butler M, Garrigue JL, Kimber I, Lea L, Newsome C, Roggeband R, Stropp G, Waterman S, Wiemann C: Skin sensitisation testing - New perspectives and recommendations. Food Chem Toxicol 2001;39:293-301.
43. Kimber I, Basketter DA: The murine local lymph node assay: a commentary on collaborative studies and new directions. Food Chem Toxicol 1992;30:165-169.
44. Kimber I, Dearman RJ, Basketter DA, Ryan CA, Gerberick GF: The local lymph node assay: past, present and future. Contact Dermatitis 2002;47:315-328.
45. Kimber I, Dearman RJ, Scholes EW, Basketter DA: The local lymph node assay: developments and applications. Toxicology 1994;93:13-31.
46. Basketter DA, Gerberick GF, Kimber I, Loveless SE: The local lymph node assay: a viable alternative to currently accepted skin sensitization tests. Food Chem Toxicol 1996;34:985-997.
47. Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA: Local lymph node assay: validation assessment for regulatory purposes. Am J Contact Dermat 2000;11:3-18.
48. Balls M, Hellsten E: Statement on the validity of the local lymph node assay for skin sensitisation testing. ECVAM joint research centre, European commission, Ispra. Altern Lab Anim 2000;28:366-367.
49. Basketter DA, Lea LJ, Cooper KJ, Ryan CA, Gerberick GF, Dearman RJ, Kimber I: Identification of metal allergens in the local lymph node assay. Am J Contact Dermat 1999;10:207-212.
50. Basketter DA, Selbie E, Scholes EW, Lees D, Kimber I, Botham PA: Results with OECD recommended positive control sensitizers in the maximization, Buehler and local lymph node assays. Food Chem Toxicol 1993;31:63-67.
51. Durand G, de Burlet G, Virat M, Nauman BD: Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates. Contact Dermatitis 2003;49:148-154.
52. Gerberick GF, Ryan CA, Kern PS, Schlatter H, Dearman RJ, Kimber I, Patlewicz GY, Basketter DA: Compilation of historical local lymph node data for evaluation of skin sensitization alternative methods. Dermatitis 2005;16:157-202.
53. Hans-Werner V, Jurgen AH: The local lymph node assay being too sensitive? Arch Toxicol 2005;79:721-728.
54. McGarry HF: The murine local lymph node assay: regulatory and potency considerations under reach. Toxicology 2007;238:71-89.
55. Basketter DA, Gerberick GF, Kimber I: Strategies for identifying false positive responses in predictive skin sensitization tests. Food Chem Toxicol 1998;36:327-333.
56. Basketter DA, Kimber I: Information derived from sensitization test methods: test sensitivity, false positives and false negatives. Contact Dermatitis 2007;56:1-4.
57. Cockshott A, Evans P, Ryan CA, Gerberick GF, Betts CJ, Dearman RJ, Kimber I, Basketter DA: The local lymph node assay in practice: a current regulatory perspective. Hum Exp Toxicol 2006;25:387-394.
58. Loveless SE, Ladics GS, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, House RV, Hilton J, Dearman RJ, Kimber I: Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 1996;108:141-152.
59. Basketter DA: Skin sensitization: strategies for risk assessment and risk management. Br J Dermatol, submitted.
60. Vickers C, Loveren HV, Cockshott A, Gabel T, Gundert-Remy U, Jong WHD, Matheson J, McGarry H, Musset L, Selgrade MK, Api AM, Kuper CF, Arts JH, Basketter D, Gerberick GM, Griem P, Johansen JD, Liden C, McMahon TF, Chen J, Patlewicz G, Ryan CA, Takeyoshi M, Vohr H-W: Skin sensitization in chemical risk assessment: report of a WHO/IPCS international workshop focusing on dose-response assessment. Regul Toxicol Pharmacol, in press.
61. Basketter DA, Balikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJ: Use of the local lymph node assay for the estimation of relative contact allergenic potency. Contact Dermatitis 2000;42:344-348.
62. Kimber I, Basketter DA: Contact sensitization: a new approach to risk assessment. Hum Ecol Risk Assess 1997;3:385-395.
63. Roberts DW, Basketter DA: A quantitative structure activity/dose response relationship for contact allergic potential of alkyl group transfer agents. Contact Dermatitis 1990;23:331-335.
64. Cronin MT, Basketter DA: Multivariate QSAR analysis of a skin sensitization database. SAR QSAR Environ Res 1994;2:159-179.
65. Basketter DA, Roberts DW, Cronin M, Scholes EW: The value of the local lymph node assay in quantitative structure-activity investigations. Contact Dermatitis 1992;27:137-142.
66. Kimber I, Hilton J, Dearman RJ, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, Ladics GS, Loveless SE, House RV, et al: An international evaluation of the murine local lymph node assay and comparison of modified procedures. Toxicology 1995;103:63-73.
67. Basketter DA, Lea LJ, Cooper K, Stocks J, Dickens A, Pate I, Dearman RJ, Kimber I: Threshold for classification as a skin sensitizer in the local lymph node assay: a statistical evaluation. Food Chem Toxicol 1999;37:1167-1174.
68. Basketter DA, Lea LJ, Dickens A, Briggs D, Pate I, Dearman RJ, Kimber I: A comparison of statistical approaches to the derivation of EC3 values from local lymph node assay dose responses. J Appl Toxicol 1999;19:261-266.
69. De Jong WH, Van Och FM, Den Hartog Jager CF, Spiekstra SW, Slob W, Vandebriel RJ, Van Loveren H: Ranking of allergenic potency of rubber chemicals in a modified local lymph node assay. Toxicol Sci 2002;66:226-232.
70. Ryan CA, Chaney JG, Gerberick GF, Kern PS, Dearman RJ, Kimber I, Basketter DA: Extrapolating local lymph node assay EC3 values to estimate relative sensitizing potency. Cutan Ocul Toxicol 2007;26:135-145.
71. Basketter DA, Gerberick F, Kimber I: The local lymph node assay and the assessment of relative potency: status of validation. Contact Dermatitis 2007;57:70-75.
72. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG: Contact allergenic potency: correlation of human and local lymph node assay data. Am J Contact Dermat 2001;12:156-161.
73. Griem P, Goebel C, Scheffler H: Proposal for a risk assessment methodology for skin sensitization based on sensitization potency data. Regul Toxicol Pharmacol 2003;38:269-290.
74. Schneider K, Akkan Z: Quantitative relationship between the local lymph node assay and human skin sensitization assays. Regul Toxicol Pharmacol 2004;39:245-255.
75. Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I: Predictive identification of human skin sensitization thresholds. Contact Dermatitis 2005;53:260-267.
76. Divkovic M, Pease CK, Gerberick GF, Basketter DA: Hapten-protein binding: from theory to practical application in the in vitro prediction of skin sensitization. Contact Dermatitis 2005;53:189-200.
77. Casati S, Aeby P, Basketter DA, Cavani A, Gennari A, Gerberick GF, Griem P, Hartung T, Kimber I, Lepoittevin J-P, Meade BJ, Pallardy M, Rougier N, Rousset F, Rubinstenn G, Sallusto F, Verheyen GR, Zuang V: Dendritic cells as a tool for the predictive identification of skin sensitisation hazard: the report and recommendations of ECVAM workshop 51. Altern Lab Anim 2005;33:47-62.
78. Jowsey IR, Basketter DA, Westmoreland C, Kimber I: A future approach to measuring relative skin sensitising potency: a proposal. J Appl Toxicol 2006;26:341-350.
79. Rovida C, Basketter D, Casati S, de Silva O, Hermans H, Kimber I, Manou I, Weltzien HU, Roggen E: Management of an integrated project (Sens-it-iv) to develop in vitro tests to assess sensitisation. Altern Lab Anim 2007;35:317-322.
80. Ryan CA, Kimber I, Basketter DA, Pallardy M, Gildea LA, Gerberick GF: Dendritic cells and skin sensitization: biological roles and uses in hazard identification. Toxicol Appl Pharmacol 2007;221:384-394.
81. Basketter DA, Maxwell G: Identification and characterization of allergens: in vitro approaches. Expert Rev Dermatol 2007;2:471-479.
82. Langton K, Patlewicz GY, Long A, Marchant CA, Basketter DA: Structure-activity relationships for skin sensitization: recent improvements to Derek for Windows. Contact Dermatitis 2006;55:342-347.
83. Gerberick GF, Vassallo JD, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP: Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci 2004;81:332-343.
84. Gerberick GF, Vassallo JD, Foertsch LM, Price BB, Chaney JG, Lepoittevin JP: Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol Sci 2007;97:417-427.
85. Natsch A, Gfeller H, Rothaupt M, Ellis G: Utility and limitations of a peptide reactivity assay to predict fragrance allergens in vitro. Toxicol In Vitro 2007;21:1220-1226.
86. Gerberick GF, Aleksic M, Basketter DA, Casati S, Karlberg A-T, Kern P, Kimber I, Lepoittevin J-P, Natsch A, Ovigne J-M, Rovida C, Sakaguchi H, Schultz T: Chemical reactivity measurement and the predictive identification of skin sensitizers. Altern Lab Anim, in press.
87. Ashikaga T, Yoshida Y, Hirota M, Yoneyama K, Itagaki H, Sakaguchi H, Miyazawa M, Ito Y, Suzuki H, Toyoda H: Development of an in vitro skin sensitization test using human cell lines: the human Cell Line Activation Test (h-CLAT). 1. Optimization of the h-CLAT protocol. Toxicol In Vitro 2006;20:767-773.
88. Python F, Goebel C, Aeby P: Assessment of the U937 cell line for the detection of contact allergens. Toxicol Appl Pharmacol 2007;220:113-124.
89. Sakaguchi H, Ashikaga T, Miyazawa M, Yoshida Y, Ito Y, Yoneyama K, Hirota M, Itagaki H, Toyoda H, Suzuki H: Development of an in vitro skin sensitization test using human cell lines: human cell line activation test (h-CLAT). 2. An inter-laboratory study of the h-CLAT. Toxicol In Vitro 2006;20:774-784.
90. McFadden JP, Basketter DA: Contact allergy, irritancy and 'danger'. Contact Dermatitis 2000;42:123-127.
91. Natsch A, Emter R: Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol Sci 2008;102:110-119.